Study analysis · iScience · 2026
What if your muscle supplement could help your immune system kill cancer?
Creatine helps immune cells stay energized so they can better find and destroy cancer cells in mice and human lab tests.
Overview
What the study found
The study in plain English — the bottom line, every takeaway we extracted, and what to do with them.
In simple terms
This study shows that in mice and human cells in a lab, creatine helps immune cells work better and fight tumors. But it doesn't prove that taking creatine pills will help people with cancer — we don't know yet if it works the same way in real patients.
What’s the bottom line?
Your immune system has special cells called dendritic cells that teach T cells to attack cancer. These cells need lots of energy. Creatine, a supplement athletes use, helps these cells store more energy so they work better.
How strong is this study?
The scientists did a really thorough job testing how creatine affects immune cells using smart experiments and lots of data. But because they didn't test it in real people with cancer, we can't be sure it will work the same way outside the lab — so we need more studies before we can trust it as a treatment.
40 / 100
- COI disclosure+40/40
- Data availabilitydata not shared
- Code availabilitycode not shared
19 / 100
- Randomizationnot randomized
- Blindingblinding unclear
- Control group+15/15
- Sample sizeno sample size reported
- Follow-upno follow-up reported
100 / 100
54 / 100
- P-values+15/15
- Effect size+20/20
- Confidence intervalsno confidence intervals
- Pre-registrationnot pre-registered
Each component is scored out of 100 and then capped by the study design — a case series cannot reach the ceiling a randomised trial can, however well it is reported.
Where it sits
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 548 / 100
Probability of being correct
Groups of people are followed over time to see who develops an outcome. Strong for identifying risk factors and associations, but cannot prove causation as firmly as RCTs.
This design cannot establish causation — the findings describe an association, not a cause. This study is not a randomized controlled trial and lacks randomization and blinding. While it includes controlled experiments in mice and human cells, the absence of randomization and the use of animal and in vitro models prevent definitive causal claims in humans. The findings are mechanistic and correlative within the experimental systems used.
No Conflicts
No conflicts of interest identified
No conflicts of interest or funding disclosures were reported in the study text. The research appears to be independently conducted with no industry ties or financial relationships disclosed.
The study lacks any declared funding sources or conflict of interest statement. While the absence of disclosure does not imply conflict, it limits transparency. All data presented are from academic institutions and no industry affiliations or financial relationships are indicated.
Key takeaways
- 01
Creatine made dendritic cells produce more energy (ATP), activate more strongly, and better teach T cells to kill tumor cells.
- 02
In mice, tumors grew slower.
- 03
In human cells, dendritic cells also became more active.
- 04
Yes — this suggests taking creatine might help cancer immunotherapy work better by making immune cells stronger, without new drugs.
Surprising findings
- Creatine doesn’t just help muscles—it’s critical for dendritic cell energy and signaling.Most people think creatine only boosts muscle performance; this study shows it’s essential for immune cell communication and inflammation control via NF-κB signaling.
- Tumor-infiltrating dendritic cells naturally ramp up creatine uptake when activated.It’s not just supplementation—cancer-fighting immune cells inside tumors actively beg for creatine by turning on their own transporters (Slc6a8), suggesting it’s a natural, evolved mechanism.
Practical takeaways
If you're undergoing cancer immunotherapy, talk to your oncologist about adding 3–5g of creatine monohydrate daily.
This study used mouse models and human cells in dishes—no clinical trials in cancer patients have been done yet. Creatine may not help everyone, and tumor type matters.
medium confidenceWhy this study matters
Creatine Fuels Immune Soldiers
Dendritic cells upregulate the creatine transporter (Slc6a8) when activated, allowing them to import creatine to buffer ATP levels. In mouse models, creatine supplementation increased intracellular ATP by up to 40% and boosted expression of activation markers like CD86 and I-Ab by 2–3 fold, enhancing their ability to prime tumor-specific T cells.
You don’t need a new drug—just a common supplement many already take for gym gains—to potentially supercharge your immune system’s cancer-fighting power.
Tumors Shrink With Creatine
In the B16-OVA mouse melanoma model, daily creatine injections (10.5 mg per mouse) reduced tumor growth by over 50% compared to controls, while increasing the number of tumor-fighting cDC1 dendritic cells inside tumors by 2.5-fold.
This isn’t just lab data—it’s actual tumor shrinkage from a supplement you can buy at any pharmacy.
It Works in Human Cells Too
Human monocyte-derived dendritic cells (MoDCs) exposed to creatine showed 30–40% higher expression of IL-6, TNF, and IL-1B when stimulated, and boosted activation of NY-ESO-1-specific T cells—key for targeting melanoma and other cancers.
What works in mice also works in human immune cells grown in a dish—this isn’t just theoretical, it’s translatable.
Want the whole report?
Detailed mode opens the full scientific breakdown — every score component, the methodology, conflicts of interest, the evidence analysis behind each claim, and the raw study data.
Overview
What the study found
The study in plain English — the bottom line, every takeaway we extracted, and what to do with them.
Not medical advice. For informational purposes only. Always consult a healthcare professional. Terms
Your immune system has special cells called dendritic cells that teach T cells to attack cancer. These cells need lots of energy. Creatine, a supplement athletes use, helps these cells store more energy so they work better.
Research results
Creatine made dendritic cells produce more energy (ATP), activate more strongly, and better teach T cells to kill tumor cells. In mice, tumors grew slower. In human cells, dendritic cells also became more active.
What this means - more context
Yes — this suggests taking creatine might help cancer immunotherapy work better by making immune cells stronger, without new drugs.
This study investigates whether creatine supplementation enhances antitumor immunity by boosting dendritic cell (DC) activation through metabolic support.
Creatine uptake via the Slc6a8 transporter in dendritic cells preserves intracellular ATP, enhances TLR/NF-κB signaling, and increases expression of activation markers and cytokines. This improves DC-mediated priming of tumor-specific CD8+ T cells, reduces tumor growth in mice, and enhances human DC function in vitro.
Methods Used
Used CrT-KO and wild-type mice in a B16-OVA syngeneic melanoma model; supplemented creatine intraperitoneally; performed in vitro DC/T cell co-cultures with OT1 and NY-ESO-1-specific T cells; used LC-MS/MS metabolomics, scRNA-seq, flow cytometry, and Western blotting in mouse and human monocyte-derived DCs.
Main Finding
Creatine supplementation significantly enhanced dendritic cell activation, increased intratumoral cDC1 abundance, and suppressed tumor growth in mice; it also boosted activation and T cell priming capacity of human monocyte-derived DCs.
Confidence Level
High — robust experimental design with genetic knockouts, pharmacological interventions, multi-omics validation, and translational human cell data; statistical significance reported with p-values and effect sizes.
Study Flags
Red Flags
- •Relies on a single mouse tumor model (B16-OVA)
- •Human data limited to in vitro monocyte-derived DCs
- •No clinical outcomes or human trial data yet
Surprising Findings
Creatine doesn’t just help muscles—it’s critical for dendritic cell energy and signaling.
Most people think creatine only boosts muscle performance; this study shows it’s essential for immune cell communication and inflammation control via NF-κB signaling.
Practical Takeaways
If you're undergoing cancer immunotherapy, talk to your oncologist about adding 3–5g of creatine monohydrate daily.
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 548 / 100
Probability of being correct
Groups of people are followed over time to see who develops an outcome. Strong for identifying risk factors and associations, but cannot prove causation as firmly as RCTs.
Human Cohort Study
Subject
Moderate probability
on the GRADE evidence scale
This study shows that in mice and human cells in a lab, creatine helps immune cells work better and fight tumors. But it doesn't prove that taking creatine pills will help people with cancer — we don't know yet if it works the same way in real patients.
No conflicts of interest were detected in this study. No score impact.
Strengths
- Comprehensive mechanistic analysis using genetic knockout models
- Use of both in vitro and in vivo models to validate findings
- Validation in human cells (MoDCs) supporting translational relevance
Weaknesses
- No randomization or blinding in experimental groups
- Lack of human clinical data or trials
- Reliance on a single syngeneic mouse tumor model
Methodology
Evidence Keywords
Statistical Reporting
Not medical advice. For informational purposes only. Always consult a healthcare professional. Terms
Your immune system has special cells called dendritic cells that teach T cells to attack cancer. These cells need lots of energy. Creatine, a supplement athletes use, helps these cells store more energy so they work better.
Research results
Creatine made dendritic cells produce more energy (ATP), activate more strongly, and better teach T cells to kill tumor cells. In mice, tumors grew slower. In human cells, dendritic cells also became more active.
What this means - more context
Yes — this suggests taking creatine might help cancer immunotherapy work better by making immune cells stronger, without new drugs.
This study investigates whether creatine supplementation enhances antitumor immunity by boosting dendritic cell (DC) activation through metabolic support.
Creatine uptake via the Slc6a8 transporter in dendritic cells preserves intracellular ATP, enhances TLR/NF-κB signaling, and increases expression of activation markers and cytokines. This improves DC-mediated priming of tumor-specific CD8+ T cells, reduces tumor growth in mice, and enhances human DC function in vitro.
Methods Used
Used CrT-KO and wild-type mice in a B16-OVA syngeneic melanoma model; supplemented creatine intraperitoneally; performed in vitro DC/T cell co-cultures with OT1 and NY-ESO-1-specific T cells; used LC-MS/MS metabolomics, scRNA-seq, flow cytometry, and Western blotting in mouse and human monocyte-derived DCs.
Main Finding
Creatine supplementation significantly enhanced dendritic cell activation, increased intratumoral cDC1 abundance, and suppressed tumor growth in mice; it also boosted activation and T cell priming capacity of human monocyte-derived DCs.
Confidence Level
High — robust experimental design with genetic knockouts, pharmacological interventions, multi-omics validation, and translational human cell data; statistical significance reported with p-values and effect sizes.
Study Flags
Red Flags
- •Relies on a single mouse tumor model (B16-OVA)
- •Human data limited to in vitro monocyte-derived DCs
- •No clinical outcomes or human trial data yet
Surprising Findings
Creatine doesn’t just help muscles—it’s critical for dendritic cell energy and signaling.
Most people think creatine only boosts muscle performance; this study shows it’s essential for immune cell communication and inflammation control via NF-κB signaling.
Practical Takeaways
If you're undergoing cancer immunotherapy, talk to your oncologist about adding 3–5g of creatine monohydrate daily.
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 548 / 100
Probability of being correct
Groups of people are followed over time to see who develops an outcome. Strong for identifying risk factors and associations, but cannot prove causation as firmly as RCTs.
Human Cohort Study
Subject
Moderate probability
on the GRADE evidence scale
This study shows that in mice and human cells in a lab, creatine helps immune cells work better and fight tumors. But it doesn't prove that taking creatine pills will help people with cancer — we don't know yet if it works the same way in real patients.
No conflicts of interest were detected in this study. No score impact.
Strengths
- Comprehensive mechanistic analysis using genetic knockout models
- Use of both in vitro and in vivo models to validate findings
- Validation in human cells (MoDCs) supporting translational relevance
Weaknesses
- No randomization or blinding in experimental groups
- Lack of human clinical data or trials
- Reliance on a single syngeneic mouse tumor model
Methodology
Evidence Keywords
Statistical Reporting
Scoring
How strong is this study?
The scientists did a really thorough job testing how creatine affects immune cells using smart experiments and lots of data. But because they didn't test it in real people with cancer, we can't be sure it will work the same way outside the lab — so we need more studies before we can trust it as a treatment.
40 / 100
- COI disclosure+40/40
- Data availabilitydata not shared
- Code availabilitycode not shared
19 / 100
- Randomizationnot randomized
- Blindingblinding unclear
- Control group+15/15
- Sample sizeno sample size reported
- Follow-upno follow-up reported
100 / 100
54 / 100
- P-values+15/15
- Effect size+20/20
- Confidence intervalsno confidence intervals
- Pre-registrationnot pre-registered
Each component is scored out of 100 and then capped by the study design — a case series cannot reach the ceiling a randomised trial can, however well it is reported.
Where it sits
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 548 / 100
Probability of being correct
Groups of people are followed over time to see who develops an outcome. Strong for identifying risk factors and associations, but cannot prove causation as firmly as RCTs.
This design cannot establish causation — the findings describe an association, not a cause. This study is not a randomized controlled trial and lacks randomization and blinding. While it includes controlled experiments in mice and human cells, the absence of randomization and the use of animal and in vitro models prevent definitive causal claims in humans. The findings are mechanistic and correlative within the experimental systems used.
No Conflicts
No conflicts of interest identified
No conflicts of interest or funding disclosures were reported in the study text. The research appears to be independently conducted with no industry ties or financial relationships disclosed.
The study lacks any declared funding sources or conflict of interest statement. While the absence of disclosure does not imply conflict, it limits transparency. All data presented are from academic institutions and no industry affiliations or financial relationships are indicated.
Standing
Who’s using this study?
The videos and claims on this site that lean on this study, and the researchers who wrote it.
1 video from Dr. William Wallace cite this study, drawing 4 claims from it.
- Strong evidence
At least some randomized or controlled trials support this claim.
Evidence - Correlational evidence
The evidence shows a real association, but the studies are observational, so they cannot prove cause and effect. Stronger studies could still change the picture.
Evidence - Correlational evidence
The evidence shows a real association, but the studies are observational, so they cannot prove cause and effect. Stronger studies could still change the picture.
Evidence
- Contradicted
Evidence contradicts this claim.
Evidence